Andreas Busch, PhD, Chief Innovation Officer is responsible for leading R&D, technical operations, and driving both Absci's internal and partner programs. Dr. Busch brings substantial R&D expertise to Absci's leadership team as a world-renowned leader in drug discovery and has led R&D efforts for some of the globe's top pharma companies including Sanofi, Bayer, and Shire. His leadership has resulted in over 10 commercial drugs starting from bench to FDA approval with several more in late stage clinical development. He holds the title of Extraordinary Professor of Pharmacology at the Johann Wolfgang Goethe-University in Frankfurt, Germany, where he also received his PhD in Pharmacology